Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tomography, Optical Coherence | 27 | 2021 | 1008 | 5.82 | Why? |
| Retinal Ganglion Cells | 8 | 2021 | 80 | 4.59 | Why? |
| Nerve Fibers | 8 | 2021 | 73 | 4.13 | Why? |
| Intraocular Pressure | 12 | 2021 | 276 | 3.23 | Why? |
| Optic Disk | 6 | 2021 | 66 | 3.05 | Why? |
| Glaucoma | 8 | 2018 | 225 | 2.92 | Why? |
| Tonometry, Ocular | 7 | 2019 | 108 | 2.60 | Why? |
| Retina | 5 | 2020 | 424 | 2.20 | Why? |
| Glaucoma, Open-Angle | 3 | 2018 | 55 | 2.02 | Why? |
| Lens Implantation, Intraocular | 4 | 2018 | 62 | 2.01 | Why? |
| Myopia | 5 | 2018 | 189 | 1.93 | Why? |
| Trabecular Meshwork | 7 | 2018 | 11 | 1.82 | Why? |
| Phakic Intraocular Lenses | 4 | 2018 | 11 | 1.71 | Why? |
| Cornea | 5 | 2018 | 410 | 1.70 | Why? |
| Iris | 4 | 2018 | 27 | 1.66 | Why? |
| Anterior Chamber | 4 | 2018 | 26 | 1.64 | Why? |
| Ranibizumab | 4 | 2019 | 103 | 1.64 | Why? |
| Ocular Hypertension | 3 | 2018 | 35 | 1.59 | Why? |
| Lenses, Intraocular | 2 | 2018 | 15 | 1.47 | Why? |
| Wet Macular Degeneration | 2 | 2019 | 102 | 1.30 | Why? |
| Conjunctivitis | 2 | 2021 | 318 | 1.25 | Why? |
| Optic Nerve | 3 | 2021 | 123 | 1.25 | Why? |
| Retinal Vessels | 6 | 2021 | 255 | 1.24 | Why? |
| Conjunctivitis, Viral | 2 | 2020 | 301 | 1.19 | Why? |
| Visual Acuity | 10 | 2019 | 790 | 1.19 | Why? |
| Refraction, Ocular | 3 | 2018 | 108 | 0.99 | Why? |
| Cytochrome P-450 CYP1B1 | 2 | 2019 | 10 | 0.91 | Why? |
| Corneal Stroma | 2 | 2017 | 26 | 0.87 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2018 | 665 | 0.86 | Why? |
| Keratoconus | 2 | 2017 | 42 | 0.82 | Why? |
| Hydrophthalmos | 1 | 2019 | 2 | 0.81 | Why? |
| Bodily Secretions | 1 | 2020 | 109 | 0.80 | Why? |
| Prostheses and Implants | 2 | 2017 | 116 | 0.80 | Why? |
| Phacoemulsification | 2 | 2018 | 102 | 0.79 | Why? |
| Transducers, Pressure | 1 | 2018 | 4 | 0.76 | Why? |
| Vision, Ocular | 1 | 2018 | 37 | 0.74 | Why? |
| Scattering, Radiation | 1 | 2018 | 31 | 0.74 | Why? |
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2017 | 8 | 0.69 | Why? |
| Oculomotor Muscles | 1 | 2017 | 24 | 0.67 | Why? |
| Ophthalmic Solutions | 1 | 2017 | 136 | 0.66 | Why? |
| Fluorescein Angiography | 6 | 2021 | 426 | 0.65 | Why? |
| Strabismus | 1 | 2017 | 34 | 0.65 | Why? |
| Contact Lenses | 1 | 2018 | 108 | 0.64 | Why? |
| Fourier Analysis | 5 | 2018 | 42 | 0.61 | Why? |
| Cataract Extraction | 1 | 2019 | 201 | 0.61 | Why? |
| Cataract | 1 | 2019 | 186 | 0.60 | Why? |
| Antihypertensive Agents | 2 | 2018 | 1962 | 0.59 | Why? |
| Conjunctiva | 2 | 2020 | 620 | 0.57 | Why? |
| Ophthalmologic Surgical Procedures | 1 | 2017 | 211 | 0.55 | Why? |
| Intravitreal Injections | 4 | 2019 | 347 | 0.54 | Why? |
| Corneal Topography | 3 | 2018 | 45 | 0.52 | Why? |
| Macula Lutea | 4 | 2021 | 87 | 0.52 | Why? |
| Eye Infections, Viral | 1 | 2020 | 517 | 0.49 | Why? |
| Tears | 4 | 2020 | 400 | 0.46 | Why? |
| DNA | 1 | 2017 | 778 | 0.45 | Why? |
| Hemoglobins | 1 | 2017 | 958 | 0.44 | Why? |
| Cross-Sectional Studies | 20 | 2021 | 53120 | 0.40 | Why? |
| Choroidal Neovascularization | 1 | 2011 | 96 | 0.40 | Why? |
| Healthy Volunteers | 4 | 2021 | 1444 | 0.40 | Why? |
| Sex Characteristics | 1 | 2018 | 1120 | 0.40 | Why? |
| Proteins | 1 | 2017 | 921 | 0.39 | Why? |
| Prospective Studies | 14 | 2021 | 43301 | 0.38 | Why? |
| Vascular Endothelial Growth Factor A | 3 | 2019 | 604 | 0.38 | Why? |
| Software | 2 | 2018 | 2501 | 0.38 | Why? |
| Preservatives, Pharmaceutical | 2 | 2018 | 11 | 0.37 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.36 | Why? |
| Follow-Up Studies | 10 | 2019 | 17020 | 0.35 | Why? |
| Aqueous Humor | 2 | 2018 | 82 | 0.33 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.33 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.30 | Why? |
| Angiogenesis Inhibitors | 3 | 2019 | 395 | 0.30 | Why? |
| Male | 35 | 2021 | 367725 | 0.30 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.29 | Why? |
| Prosthesis Design | 2 | 2018 | 594 | 0.29 | Why? |
| Female | 35 | 2021 | 380317 | 0.29 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.27 | Why? |
| Humans | 49 | 2021 | 930598 | 0.24 | Why? |
| Primary Health Care | 1 | 2021 | 4839 | 0.24 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.23 | Why? |
| Aging | 1 | 2018 | 3581 | 0.22 | Why? |
| Eye Proteins | 1 | 2020 | 42 | 0.21 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.21 | Why? |
| Spain | 6 | 2021 | 15545 | 0.21 | Why? |
| Organ Size | 1 | 2021 | 384 | 0.21 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.20 | Why? |
| Hypertensive Retinopathy | 1 | 2019 | 12 | 0.20 | Why? |
| Sclera | 1 | 2018 | 31 | 0.19 | Why? |
| Optical Imaging | 1 | 2020 | 197 | 0.19 | Why? |
| Child | 10 | 2021 | 70012 | 0.19 | Why? |
| Bruch Membrane | 1 | 2018 | 6 | 0.19 | Why? |
| Uveitis, Intermediate | 1 | 2017 | 4 | 0.19 | Why? |
| Dose-Response Relationship, Drug | 2 | 2019 | 3776 | 0.18 | Why? |
| Fluorescein | 1 | 2017 | 66 | 0.18 | Why? |
| Microscopy, Acoustic | 1 | 2017 | 20 | 0.18 | Why? |
| Purinergic P1 Receptor Agonists | 1 | 2017 | 1 | 0.18 | Why? |
| Prostaglandins F, Synthetic | 1 | 2017 | 2 | 0.18 | Why? |
| Polyglycolic Acid | 1 | 2017 | 14 | 0.17 | Why? |
| Benzalkonium Compounds | 1 | 2017 | 42 | 0.17 | Why? |
| Reproducibility of Results | 4 | 2019 | 11304 | 0.17 | Why? |
| Glaucoma, Neovascular | 1 | 2016 | 6 | 0.17 | Why? |
| rho-Associated Kinases | 1 | 2017 | 32 | 0.17 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.17 | Why? |
| Hydrodynamics | 1 | 2018 | 177 | 0.17 | Why? |
| Biomechanical Phenomena | 1 | 2018 | 291 | 0.17 | Why? |
| Nitric Oxide Donors | 1 | 2017 | 53 | 0.17 | Why? |
| Drug Liberation | 1 | 2017 | 141 | 0.16 | Why? |
| Adult | 15 | 2021 | 244371 | 0.16 | Why? |
| Aged | 16 | 2020 | 215776 | 0.16 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.16 | Why? |
| Equipment Design | 2 | 2018 | 3095 | 0.16 | Why? |
| Vitamin E | 1 | 2017 | 128 | 0.16 | Why? |
| Visual Fields | 1 | 2017 | 123 | 0.15 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.15 | Why? |
| Bevacizumab | 1 | 2016 | 149 | 0.15 | Why? |
| Microspheres | 1 | 2017 | 261 | 0.15 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.15 | Why? |
| Prosthesis Implantation | 1 | 2017 | 261 | 0.14 | Why? |
| Uveitis | 1 | 2017 | 233 | 0.13 | Why? |
| Lactic Acid | 1 | 2017 | 393 | 0.13 | Why? |
| Incidental Findings | 1 | 2018 | 487 | 0.13 | Why? |
| Aged, 80 and over | 8 | 2020 | 88759 | 0.13 | Why? |
| Rabbits | 1 | 2017 | 1171 | 0.13 | Why? |
| Young Adult | 8 | 2019 | 93724 | 0.12 | Why? |
| RNA | 1 | 2020 | 1278 | 0.12 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.12 | Why? |
| Physical Examination | 1 | 2018 | 755 | 0.12 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.11 | Why? |
| Antibodies, Monoclonal | 1 | 2011 | 8041 | 0.11 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.11 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.11 | Why? |
| Retreatment | 1 | 2011 | 186 | 0.11 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.10 | Why? |
| Recurrence | 2 | 2017 | 3675 | 0.10 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.10 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.10 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.09 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.09 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.09 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.08 | Why? |
| Treatment Outcome | 4 | 2019 | 51732 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Time Factors | 3 | 2019 | 31397 | 0.08 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.08 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.07 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.07 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.06 | Why? |
| Computer Simulation | 1 | 2018 | 4982 | 0.06 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.06 | Why? |
| Child, Preschool | 3 | 2019 | 36283 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.05 | Why? |
| Keratitis | 1 | 2020 | 102 | 0.05 | Why? |
| Lens, Crystalline | 1 | 2018 | 14 | 0.05 | Why? |
| Axial Length, Eye | 1 | 2016 | 6 | 0.04 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.04 | Why? |
| Remission, Spontaneous | 1 | 2017 | 186 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| Infant | 1 | 2019 | 30274 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.04 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Chemotherapy, Adjuvant | 1 | 2016 | 606 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.03 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 9335 | 0.02 | Why? |
| Animals | 1 | 2017 | 78931 | 0.02 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |